USANA Health Sciences (NYSE:USNA) Shares Gap Up on Earnings Beat

USANA Health Sciences, Inc. (NYSE:USNA)’s share price gapped up before the market opened on Wednesday following a better than expected earnings announcement. The stock had previously closed at $31.96, but opened at $35.67. USANA Health Sciences shares last traded at $32.93, with a volume of 84,067 shares changing hands.

The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.15. The business had revenue of $213.61 million during the quarter, compared to analysts’ expectations of $208.82 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%.

Analysts Set New Price Targets

USNA has been the topic of a number of recent analyst reports. DA Davidson upped their target price on shares of USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a research report on Thursday, January 2nd. StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Finally, Sidoti downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th.

Hedge Funds Weigh In On USANA Health Sciences

Hedge funds and other institutional investors have recently bought and sold shares of the company. Barclays PLC lifted its position in shares of USANA Health Sciences by 111.9% during the third quarter. Barclays PLC now owns 27,737 shares of the company’s stock worth $1,052,000 after purchasing an additional 14,647 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in USANA Health Sciences by 14,068.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock worth $1,472,000 after buying an additional 38,547 shares in the last quarter. Assenagon Asset Management S.A. lifted its holdings in USANA Health Sciences by 13.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock worth $4,702,000 after buying an additional 14,756 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of USANA Health Sciences by 4.5% in the third quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock worth $11,269,000 after acquiring an additional 12,898 shares in the last quarter. Finally, State Street Corp grew its stake in shares of USANA Health Sciences by 0.6% in the third quarter. State Street Corp now owns 435,164 shares of the company’s stock worth $16,501,000 after acquiring an additional 2,782 shares in the last quarter. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

USANA Health Sciences Stock Up 3.0 %

The firm has a market cap of $627.66 million, a PE ratio of 11.64, a price-to-earnings-growth ratio of 0.93 and a beta of 0.87. The business has a 50-day moving average price of $33.65 and a two-hundred day moving average price of $36.64.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.